clodronic acid has been researched along with Fracture, Pathologic in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (53.33) | 18.2507 |
| 2000's | 4 (26.67) | 29.6817 |
| 2010's | 3 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ashcroft, AJ; Bell, SE; Byrne, J; Child, JA; Cocks, K; Cook, G; Davies, FE; Drayson, MT; Feyler, S; Gregory, WM; Jackson, GH; Morgan, GJ; Navarro-Coy, N; Owen, RG; Roddie, H; Ross, FM; Rudin, C; Szubert, AJ; Wu, P | 1 |
| Dimopoulos, MA; Terpos, E | 1 |
| Morgans, AK; Smith, MR | 1 |
| Cook, R; Major, PP | 1 |
| Saad, F | 1 |
| Langdahl, B; Mosekilde, L; Vestergaard, P | 1 |
| Ashley, S; Hanson, J; Kanis, JA; McCloskey, E; Paterson, AH; Powles, TJ | 1 |
| Kanis, JA | 1 |
| Chapman, C; Drayson, MT; Dunn, J; Kanis, JA; MacLennan, IC; McCloskey, EV | 1 |
| Califano, L; Maremonti, P; Zupi, A | 1 |
| Bastert, G; Diel, IJ; Solomayer, EF | 1 |
| Elomaa, I; Laakso, M; Lahtinen, R; Palva, I; Virkkunen, P | 1 |
| Ashley, S; Ernst, DS; Kanis, JA; McCloskey, EV; Paterson, AH; Powles, TJ | 1 |
| Biermann, WA; Cantor, RI; Fellin, FM; Hopkins, L; Jakobowski, J; Newbold, RC | 1 |
7 review(s) available for clodronic acid and Fracture, Pathologic
| Article | Year |
|---|---|
Bone-targeted agents: preventing skeletal complications in prostate cancer.
Topics: Androgen Antagonists; Antibodies, Monoclonal, Humanized; Bone Density; Bone Neoplasms; Clinical Trials as Topic; Clodronic Acid; Denosumab; Diphosphonates; Fractures, Spontaneous; Humans; Imidazoles; Male; Osteoclasts; Osteoporosis; Pamidronate; Prostatic Neoplasms; Quality of Life; Samarium; Toremifene; Zoledronic Acid | 2012 |
Efficacy of bisphosphonates in the management of skeletal complications of bone metastases and selection of clinical endpoints.
Topics: Bone Neoplasms; Breast Neoplasms; Clodronic Acid; Data Interpretation, Statistical; Diphosphonates; Female; Fractures, Spontaneous; Humans; Hypercalcemia; Imidazoles; Male; Models, Statistical; Pain; Pamidronate; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Spinal Cord Compression; Treatment Outcome; Zoledronic Acid | 2002 |
Fracture prevention in postmenopausal women.
Topics: Aged; Alendronate; Bone Density Conservation Agents; Calcitonin; Calcium; Clodronic Acid; Diphosphonates; Etidronic Acid; Female; Fractures, Spontaneous; Hormone Replacement Therapy; Humans; Ibandronic Acid; Osteoporosis, Postmenopausal; Pamidronate; Parathyroid Hormone; Risedronic Acid; Selective Estrogen Receptor Modulators; Vitamin D | 2006 |
Rationale for the use of bisphosphonates in breast cancer.
Topics: Bone Neoplasms; Bone Remodeling; Breast Neoplasms; Clodronic Acid; Cost-Benefit Analysis; Diphosphonates; Fractures, Spontaneous; Humans; Hypercalcemia; Osteoclasts; Pain; Pamidronate; Quality of Life | 1996 |
Treatment of metastatic bone disease in breast cancer: bisphosphonates.
Topics: Analgesics, Non-Narcotic; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Clodronic Acid; Diphosphonates; Fractures, Spontaneous; Humans; Hypercalcemia; Incidence; Pain; Pamidronate; Patient Selection; Survival Analysis; Treatment Outcome | 2000 |
Treatment of skeletal disease in breast cancer with clodronate.
Topics: Administration, Oral; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Clodronic Acid; Combined Modality Therapy; Double-Blind Method; Fractures, Spontaneous; Humans; Hypercalcemia; Incidence; Injections, Intravenous; Osteolysis; Pain; Palliative Care; Prospective Studies; Spinal Fractures; Treatment Outcome | 1991 |
An evaluation of the potential cost reductions resulting from the use of clodronate in the treatment of metastatic carcinoma of the breast to bone.
Topics: Ambulatory Care; Analgesics; Bone Neoplasms; Breast Neoplasms; Clodronic Acid; Cost-Benefit Analysis; Costs and Cost Analysis; Epidural Space; Fractures, Spontaneous; Hospitalization; Hospitals, University; Humans; Hypercalcemia; Incidence; Length of Stay; Osteolysis; Outpatient Clinics, Hospital; Pain; Palliative Care; Philadelphia; Radiotherapy; Retrospective Studies; Spinal Neoplasms | 1991 |
5 trial(s) available for clodronic acid and Fracture, Pathologic
| Article | Year |
|---|---|
Effects of zoledronic acid versus clodronic acid on skeletal morbidity in patients with newly diagnosed multiple myeloma (MRC Myeloma IX): secondary outcomes from a randomised controlled trial.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Bone Density Conservation Agents; Clodronic Acid; Diphosphonates; Female; Fractures, Spontaneous; Humans; Imidazoles; Infusions, Intravenous; Male; Middle Aged; Multiple Myeloma; Neoplasm Staging; United Kingdom; Zoledronic Acid | 2011 |
Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer.
Topics: Administration, Oral; Adult; Aged; Bone Neoplasms; Breast Neoplasms; Calcium; Clodronic Acid; Double-Blind Method; Female; Fractures, Spontaneous; Humans; Middle Aged | 1993 |
A randomized trial of the effect of clodronate on skeletal morbidity in multiple myeloma. MRC Working Party on Leukaemia in Adults.
Topics: Aged; Analgesics, Non-Narcotic; Bone Diseases; Calcium; Clodronic Acid; Female; Fractures, Spontaneous; Humans; Hypercalcemia; Hypocalcemia; Male; Middle Aged; Multiple Myeloma; Pain; Treatment Outcome | 1998 |
Randomised, placebo-controlled multicentre trial of clodronate in multiple myeloma. Finnish Leukaemia Group.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Diseases; Calcium; Clodronic Acid; Double-Blind Method; Female; Follow-Up Studies; Fractures, Spontaneous; Humans; Hypercalcemia; Male; Middle Aged; Multiple Myeloma; Pain; Placebos | 1992 |
Treatment of skeletal disease in breast cancer with clodronate.
Topics: Administration, Oral; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Clodronic Acid; Combined Modality Therapy; Double-Blind Method; Fractures, Spontaneous; Humans; Hypercalcemia; Incidence; Injections, Intravenous; Osteolysis; Pain; Palliative Care; Prospective Studies; Spinal Fractures; Treatment Outcome | 1991 |
4 other study(ies) available for clodronic acid and Fracture, Pathologic
| Article | Year |
|---|---|
Zoledronic acid for all patients with newly diagnosed multiple myeloma?
Topics: Bone Density Conservation Agents; Clodronic Acid; Diphosphonates; Female; Fractures, Spontaneous; Humans; Imidazoles; Male; Multiple Myeloma; Zoledronic Acid | 2011 |
Bisphosphonates in prostate cancer: where are we and where should we go?
Topics: Administration, Oral; Androgen Antagonists; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Bone Neoplasms; Clodronic Acid; Diphosphonates; Fractures, Spontaneous; Humans; Imidazoles; Infusions, Intravenous; Male; Neoplasms, Hormone-Dependent; Osteoporosis; Pamidronate; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Survival Analysis; Treatment Outcome; Zoledronic Acid | 2003 |
Pathological fracture of the mandible treated with diphosphonates.
Topics: Aged; Antineoplastic Agents; Bone Resorption; Carboplatin; Carcinoma, Squamous Cell; Clodronic Acid; Fractures, Spontaneous; Humans; Male; Mandibular Fractures; Mandibular Neoplasms | 1998 |
Supportive care drug studies: some promising, some not.
Topics: Amifostine; Antineoplastic Agents; Cachexia; Clodronic Acid; Fractures, Spontaneous; Humans; Hydrazines; Neoplasms | 1992 |